Acurx Pharmaceuticals, LLC*(ACXP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ACXP Acurx Pharmaceuticals, LLC*

交易中 01-14 10:34:14 EST

2.73

+0.00

+0.00%

最高2.82	最低2.73	成交量1.72万
今开2.80	昨收2.73	日振幅3.11%
总市值641.05万	流通市值605.95万	总股本234.81万
成交额4.76万	换手率0.78%	流通股本221.95万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ACXP","market":"US","secType":"STK","nameCN":"Acurx Pharmaceuticals, LLC*","latestPrice":2.7301,"timestamp":1768404839657,"preClose":2.73,"halted":0,"volume":17228,"delay":0,"floatShares":2219500,"shares":2348100,"eps":-8.18,"marketStatus":"交易中","change":0.0001,"latestTime":"01-14 10:34:14 EST","open":2.8,"high":2.815,"low":2.73,"amount":47595.637102400004,"amplitude":0.031136,"askPrice":2.81,"askSize":200,"bidPrice":2.65,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-8.18,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1768424400000},"marketStatusCode":2,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":2.73,"preHourTrading":{"tag":"盘前","latestPrice":2.85,"preClose":2.73,"latestTime":"09:17 EST","volume":378,"amount":1057.101759,"timestamp":1768400232753},"postHourTrading":{"tag":"盘后","latestPrice":2.73,"preClose":2.73,"latestTime":"18:07 EST","volume":352,"amount":970.2,"timestamp":1768345629607},"volumeRatio":1.493895,"impliedVol":1.1448,"impliedVolPercentile":0.7482},"requestUrl":"/m/hq/s/ACXP","defaultTab":"news","newsList":[{"id":"2603163572","title":"Acurx Pharmaceuticals, Inc.盘中异动 快速跳水5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603163572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603163572?lang=zh_cn&edition=full","pubTime":"2026-01-13 04:55","pubTimestamp":1768251333,"startTime":"0","endTime":"0","summary":"北京时间2026年01月13日04时55分，Acurx Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.12%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.25%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011304553497a17e95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011304553497a17e95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BK4563","ACXP"],"gpt_icon":0},{"id":"2593413673","title":"Acurx Pharmaceuticals, Inc.盘中异动 大幅拉升5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593413673","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593413673?lang=zh_cn&edition=full","pubTime":"2025-12-22 23:34","pubTimestamp":1766417641,"startTime":"0","endTime":"0","summary":"北京时间2025年12月22日23时34分，Acurx Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.41%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222233401953b84b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222233401953b84b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","ACXP","BK4539"],"gpt_icon":0},{"id":"1183883275","title":"Acurx Pharmaceuticals将在2025年11月12日电话会议上讨论2025年第三季度财务结果并提供业务更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1183883275","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183883275?lang=zh_cn&edition=full","pubTime":"2025-10-27 20:02","pubTimestamp":1761566559,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals将在2025年11月12日的电话会议上讨论2025年第三季度的财务结果，并提供业务更新。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACXP","BK4539","BK4563"],"gpt_icon":0},{"id":"1115056977","title":"Acurx Pharmaceuticals宣布欧洲药品管理局对伊贝扎波司他治疗儿童艰难梭菌感染的儿科研究计划给予积极意见","url":"https://stock-news.laohu8.com/highlight/detail?id=1115056977","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115056977?lang=zh_cn&edition=full","pubTime":"2025-09-30 19:33","pubTimestamp":1759231998,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals宣布，欧洲药品管理局(EMA)对该公司伊贝扎波司他用于治疗儿童艰难梭菌感染的儿科研究计划给予了积极意见。这一积极意见为该药物在儿科患者中的进一步开发和应用奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4563","BK4539","ACXP"],"gpt_icon":0},{"id":"2568226163","title":"Acurx Pharmaceuticals, Inc.盘中异动 早盘急速拉升7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568226163","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568226163?lang=zh_cn&edition=full","pubTime":"2025-09-19 21:33","pubTimestamp":1758288793,"startTime":"0","endTime":"0","summary":"北京时间2025年09月19日21时33分，Acurx Pharmaceuticals, Inc.股票出现波动，股价急速上涨7.14%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509192133149538bd71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509192133149538bd71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","ACXP","BK4139","BK4539"],"gpt_icon":0},{"id":"2567612016","title":"Acurx Pharmaceuticals, Inc.盘中异动 快速跳水5.10%报4.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2567612016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567612016?lang=zh_cn&edition=full","pubTime":"2025-09-16 00:30","pubTimestamp":1757953855,"startTime":"0","endTime":"0","summary":"北京时间2025年09月16日00时30分，Acurx Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.10%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509160030559793fa2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509160030559793fa2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4563","BK4139","ACXP"],"gpt_icon":0},{"id":"1137767409","title":"Acurx Pharmaceuticals重新符合纳斯达克最低收盘价及股东权益规定","url":"https://stock-news.laohu8.com/highlight/detail?id=1137767409","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137767409?lang=zh_cn&edition=full","pubTime":"2025-09-03 19:04","pubTimestamp":1756897472,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals重新符合纳斯达克最低收盘价及股东权益规定","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4539","ACXP","BK4139"],"gpt_icon":0},{"id":"2564335121","title":"Acurx Pharmaceuticals, Inc.盘中异动 下午盘急速下挫6.28%报4.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2564335121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564335121?lang=zh_cn&edition=full","pubTime":"2025-09-03 02:22","pubTimestamp":1756837332,"startTime":"0","endTime":"0","summary":"北京时间2025年09月03日02时22分，Acurx Pharmaceuticals, Inc.股票出现波动，股价大幅跳水6.28%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903022212a70c0e9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903022212a70c0e9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4539","BK4139","ACXP"],"gpt_icon":0},{"id":"2557988505","title":"Acurx Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557988505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557988505?lang=zh_cn&edition=full","pubTime":"2025-08-08 01:06","pubTimestamp":1754586367,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日01时06分，Acurx Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.93%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808010607a47b7017&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808010607a47b7017&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ACXP","BK4139","BK4563"],"gpt_icon":0},{"id":"2556387509","title":"Acurx Pharmaceuticals, Inc.盘中异动 股价大跌5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556387509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556387509?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:44","pubTimestamp":1754315049,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时44分，Acurx Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.50%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804214409a4749512&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804214409a4749512&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","ACXP","BK4539"],"gpt_icon":0},{"id":"2556817679","title":"Acurx Pharmaceuticals, Inc.盘中异动 临近午盘股价大跌5.06%报0.310美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556817679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556817679?lang=zh_cn&edition=full","pubTime":"2025-08-01 23:32","pubTimestamp":1754062356,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日23时32分，Acurx Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.06%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801233236a6ce16a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801233236a6ce16a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACXP","BK4139","BK4539","BK4563"],"gpt_icon":0},{"id":"2555028686","title":"Acurx Pharmaceuticals, Inc.股价重挫20.42% 市值跌12.59万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555028686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555028686?lang=zh_cn&edition=full","pubTime":"2025-07-30 22:52","pubTimestamp":1753887124,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日22时52分，Acurx Pharmaceuticals, Inc.股票出现异动，股价大幅跳水20.42%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730225204a46bcfbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730225204a46bcfbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4563","BK4139","ACXP"],"gpt_icon":0},{"id":"2555052286","title":"Acurx Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.88%报0.384美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555052286","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555052286?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:54","pubTimestamp":1753797280,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时54分，Acurx Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.88%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921544094c1af00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921544094c1af00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4563","ACXP"],"gpt_icon":0},{"id":"2517691029","title":"Acurx Pharmaceuticals, Inc.盘中异动 大幅拉升7.30%报0.669美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517691029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517691029?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:32","pubTimestamp":1741185149,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时32分，Acurx Pharmaceuticals, Inc.股票出现波动，股价大幅拉升7.30%。截至发稿，该股报0.669美元/股，成交量4100股，换手率0.02%，振幅0.00%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223230989d461e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223230989d461e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","ACXP","BK4539"],"gpt_icon":0},{"id":"2516670975","title":"Acurx Pharmaceuticals, Inc.盘中异动 股价大跌5.91%报0.631美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516670975?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:02","pubTimestamp":1741100550,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时02分，Acurx Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.91%。截至发稿，该股报0.631美元/股，成交量4.7923万股，换手率0.25%，振幅4.48%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304230230989bb561&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304230230989bb561&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4539","BK4139","ACXP"],"gpt_icon":0},{"id":"2514018442","title":"Acurx Pharmaceuticals, Inc.盘中异动 急速下跌7.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514018442","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514018442?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:57","pubTimestamp":1740495451,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时57分，Acurx Pharmaceuticals, Inc.股票出现波动，股价大幅下挫7.97%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.07%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225225731962ff8a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225225731962ff8a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4563","ACXP"],"gpt_icon":0},{"id":"2513722487","title":"Acurx Pharmaceuticals, Inc.盘中异动 早盘大幅下挫5.44%报0.740美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513722487?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:38","pubTimestamp":1740407915,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时38分，Acurx Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.44%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223835abdb0f96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223835abdb0f96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACXP","BK4563","BK4139","BK4539"],"gpt_icon":0},{"id":"2513296882","title":"Acurx Pharmaceuticals, Inc.盘中异动 股价大涨8.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296882","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513296882?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:30","pubTimestamp":1740148240,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时30分，Acurx Pharmaceuticals, Inc.股票出现异动，股价大幅拉升8.41%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223040962b7b02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223040962b7b02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4563","BK4139","ACXP"],"gpt_icon":0},{"id":"2512448823","title":"Acurx Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512448823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512448823?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:36","pubTimestamp":1739975780,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时36分，Acurx Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.56%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223620988b3247&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223620988b3247&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACXP","BK4563","BK4139","BK4539"],"gpt_icon":0},{"id":"2509320679","title":"Acurx Pharmaceuticals, Inc.盘中异动 临近午盘大幅下挫5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509320679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509320679?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:35","pubTimestamp":1738859717,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时35分，Acurx Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.81%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003517a23be8ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003517a23be8ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","ACXP","BK4539","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.acurxpharma.com","stockEarnings":[{"period":"1week","weight":-0.0651},{"period":"1month","weight":-0.3292},{"period":"3month","weight":-0.6171},{"period":"6month","weight":-0.696},{"period":"1year","weight":-0.805},{"period":"ytd","weight":0.0964}],"compareEarnings":[{"period":"1week","weight":0.0028},{"period":"1month","weight":0.0176},{"period":"3month","weight":0.043},{"period":"6month","weight":0.1047},{"period":"1year","weight":0.1933},{"period":"ytd","weight":0.0174}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Acurx Pharmaceuticals, Inc.于2017年7月在特拉华州注册成立，于2018年2月开始运营。该公司是一家后期生物制药公司，专注于开发用于难治疗细菌感染的新型小分子抗生素，用于治疗被世界卫生组织列为优先病原体的细菌引起的感染（“WHO”），美国疾病控制与预防中心（“CDC”）和美国食品和药物管理局（“FDA”）。优先病原体是那些需要新抗生素来解决由WHO、CDC和FDA确定的全球抗微生物药物耐药性（“AMR”）危机的病原体。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.057022},{"month":2,"riseRate":0,"avgChangeRate":-0.089244},{"month":3,"riseRate":0.25,"avgChangeRate":-0.162505},{"month":4,"riseRate":0.5,"avgChangeRate":0.00047},{"month":5,"riseRate":0.5,"avgChangeRate":-0.04935},{"month":6,"riseRate":0.5,"avgChangeRate":0.118659},{"month":7,"riseRate":0,"avgChangeRate":-0.160175},{"month":8,"riseRate":0.2,"avgChangeRate":-0.087422},{"month":9,"riseRate":0,"avgChangeRate":-0.115354},{"month":10,"riseRate":0.6,"avgChangeRate":0.545147},{"month":11,"riseRate":0.2,"avgChangeRate":-0.181708},{"month":12,"riseRate":0.4,"avgChangeRate":-0.094208}],"exchange":"NASDAQ","name":"Acurx Pharmaceuticals, LLC*","nameEN":"Acurx Pharmaceuticals, LLC*"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Acurx Pharmaceuticals, LLC*(ACXP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Acurx Pharmaceuticals, LLC*(ACXP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Acurx Pharmaceuticals, LLC*,ACXP,Acurx Pharmaceuticals, LLC*股票,Acurx Pharmaceuticals, LLC*股票老虎,Acurx Pharmaceuticals, LLC*股票老虎国际,Acurx Pharmaceuticals, LLC*行情,Acurx Pharmaceuticals, LLC*股票行情,Acurx Pharmaceuticals, LLC*股价,Acurx Pharmaceuticals, LLC*股市,Acurx Pharmaceuticals, LLC*股票价格,Acurx Pharmaceuticals, LLC*股票交易,Acurx Pharmaceuticals, LLC*股票购买,Acurx Pharmaceuticals, LLC*股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Acurx Pharmaceuticals, LLC*(ACXP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Acurx Pharmaceuticals, LLC*(ACXP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}